[Therapeutic targeting of Notch signaling in cancer]

Mehdi Brahmi1, Olivia Bally1, Lauriane Eberst1

  • 1Centre Léon-Bérard, département de cancérologie médicale, 28, rue Laennec, 69373 Lyon cedex 08, France.

Bulletin Du Cancer
|October 17, 2017
PubMed

Insights

The Notch pathway is crucial for development and cancer. Targeting it for cancer therapy is complex, requiring further research due to its role in normal tissue homeostasis.

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Oncology

Background:

  • The Notch pathway is vital for embryonic development and adult tissue maintenance.
  • Notch signaling involves receptor cleavage, releasing the Notch intracytoplasmic domain (NICD) to regulate gene transcription.
  • Aberrant Notch signaling is implicated in various cancers, including leukemia and solid tumors.

Purpose of the Study:

  • To review the role of Notch signaling in cancer.
  • To discuss the therapeutic potential of targeting Notch signaling in oncology.
  • To highlight the challenges in developing Notch-targeted cancer therapies.

Main Methods:

  • Literature review of Notch pathway function in development and cancer.
  • Analysis of current clinical development of Notch inhibitors.
  • Discussion of the complexities of Notch signaling in cancer therapy.

Main Results:

  • Notch pathway alterations are common in various malignancies.
  • Several Notch-targeting drug classes are in clinical trials.
  • The dual role of Notch in cancer and homeostasis complicates therapeutic strategies.

Conclusions:

  • Notch signaling is a significant target for cancer drug development.
  • Clinical development of Notch inhibitors faces challenges due to pathway complexity and essential physiological roles.
  • Further preclinical and clinical studies are necessary for effective Notch-targeted cancer therapy.

Related Concept Videos

Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...